Intravenous drip therapy with corticotropin has become increasingly popular in all fields of medicine since the work of Gordon1 and Renold,2 who showed the sustained value of this type of therapy. Its application to dermatology has been reported.3 It is important to emphasize that there are in general three different types of daily intravenous drips: (1) the continuous (24 hours), (2) the intermittent (7 or 8 hours), and (3) the combined (Hampton), in which 10 mg. of corticotropin in 1,000 cc. of solution is given intravenously for 12 hours, then 10 mg. of corticotropin is administered intramuscularly.4
Advantages in the intravenous use of corticotropin are as follows:
The material and equipment needed to obtain results equal to, or better than, those with standard intramuscular uses are low in cost.
In some cases the intravenous drip therapy will stimulate the adrenal cortex when intramuscular
PRESTON RH, GOLDMAN L. INTRAVENOUS CORTICOTROPIN THERAPY IN DERMATOLOGY. AMA Arch Derm Syphilol. 1952;66(3):391–392. doi:10.1001/archderm.1952.01530280095014
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.